According to Avadel Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$3.00. In 2022 the company made an earnings per share (EPS) of -$3.30 a decrease over its 2021 EPS that were of -$1.90.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.80 | -15.31% |
2022 | -$3.30 | 73.48% |
2021 | -$1.90 | -925% |
2020 | $0.23 | -117.98% |
2019 | -$1.28 | -65.1% |
2018 | -$3.68 | -256.44% |
2017 | $2.35 | -253.77% |
2016 | -$1.53 | -208.16% |
2015 | $1.41 | -139.68% |
2014 | -$3.56 | 46.15% |
2013 | -$2.44 | -3447.86% |
2012 | $0.07280 | -114.02% |
2011 | -$0.52 | -26.38% |
2010 | -$0.71 | 4.05% |
2009 | -$0.68 | -6% |
2008 | -$0.72 | -68.35% |
2007 | -$2.28 | 6.04% |
2006 | -$2.15 | 24.17% |
2005 | -$1.73 | -300% |
2004 | $0.87 | -287.5% |
2003 | -$0.46 | -1373.73% |
2002 | $0.03623 | -113.96% |
2001 | -$0.26 | -50% |
2000 | -$0.52 | -29.41% |
1999 | -$0.74 | -19.05% |
1998 | -$0.91 | -1.56% |
1997 | -$0.92 | -16.88% |
1996 | -$1.11 |